The store will not work correctly when cookies are disabled.
3-((4-(4-bromo-2-methoxyphenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzonitrile
ID: ALA4878325
PubChem CID: 164626054
Max Phase: Preclinical
Molecular Formula: C18H12BrN3O3
Molecular Weight: 398.22
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(Br)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O
Standard InChI: InChI=1S/C18H12BrN3O3/c1-25-14-8-11(19)5-6-13(14)15-16(18(24)22-17(15)23)21-12-4-2-3-10(7-12)9-20/h2-8H,1H3,(H2,21,22,23,24)
Standard InChI Key: NYZXUVGUIAUXBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
12.1165 -22.7194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9337 -22.7194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1881 -21.9427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5251 -21.4606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8664 -21.9427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6920 -23.4177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8727 -23.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4477 -24.0964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8408 -24.8152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6633 -24.8312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0847 -24.1320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4133 -23.3811 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2266 -23.3808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6317 -24.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4442 -24.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8514 -23.3821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4400 -22.6756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6288 -22.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9656 -21.6913 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0890 -21.6906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8528 -24.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2614 -25.5026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4810 -22.6807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6640 -22.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4173 -25.5141 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
15 21 1 0
21 22 3 0
7 23 1 0
23 24 1 0
9 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 398.22 | Molecular Weight (Monoisotopic): 397.0062 | AlogP: 2.81 | #Rotatable Bonds: 4 |
Polar Surface Area: 91.22 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.68 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.77 | Np Likeness Score: -0.68 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |